| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 679 | 2013 |
| American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer GH Lyman, M Carrier, C Ay, M Di Nisio, LK Hicks, AA Khorana, AD Leavitt, ... Blood advances 5 (4), 927-974, 2021 | 594 | 2021 |
| Epidemiology and pathophysiology of cancer-associated thrombosis S Noble, J Pasi British journal of cancer 102 (1), S2-S9, 2010 | 505 | 2010 |
| Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH AA Khorana, S Noble, AYY Lee, G Soff, G Meyer, C O'Connell, M Carrier Journal of thrombosis and haemostasis 16 (9), 1891-1894, 2018 | 432 | 2018 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 369 | 2013 |
| How does the environment impact on the quality of life of advanced cancer patients? A qualitative study with implications for ward design J Rowlands, S Noble Palliative medicine 22 (6), 768-774, 2008 | 194 | 2008 |
| Cancer-associated venous thromboembolism AA Khorana, N Mackman, A Falanga, I Pabinger, S Noble, W Ageno, ... Nature reviews Disease primers 8 (1), 11, 2022 | 185 | 2022 |
| Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH BT Samuelson Bannow, A Lee, AA Khorana, JI Zwicker, S Noble, C Ay, ... Journal of Thrombosis and Haemostasis 16 (6), 1246-1249, 2018 | 170 | 2018 |
| Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial F Macbeth, S Noble, J Evans, S Ahmed, D Cohen, K Hood, D Knoyle, ... Journal of Clinical Oncology 34 (5), 488-494, 2016 | 170 | 2016 |
| COVID-19 confessions: a qualitative exploration of healthcare workers experiences of working with COVID-19 P Bennett, S Noble, S Johnston, D Jones, R Hunter BMJ open 10 (12), e043949, 2020 | 168 | 2020 |
| Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study SIR Noble, IG Finlay Palliative medicine 19 (3), 197-201, 2005 | 151 | 2005 |
| Management of challenging cases of patients with cancer‐associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH M Carrier, AA Khorana, JI Zwicker, S Noble, AYY Lee Journal of Thrombosis and Haemostasis 11 (9), 1760-1765, 2013 | 148 | 2013 |
| The assessment and impact of sarcopenia in lung cancer: a systematic literature review J Collins, S Noble, J Chester, B Coles, A Byrne BMJ open 4 (1), e003697, 2014 | 138 | 2014 |
| Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis M Giustozzi, G Agnelli, J del Toro-Cervera, FA Klok, RP Rosovsky, ... Thrombosis and haemostasis 120 (07), 1128-1136, 2020 | 130 | 2020 |
| The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH TF Wang, JI Zwicker, C Ay, I Pabinger, A Falanga, D Antic, S Noble, ... Journal of Thrombosis and Haemostasis 17 (10), 1772-1778, 2019 | 127 | 2019 |
| Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis SIR Noble, MD Shelley, B Coles, SM Williams, A Wilcock, MJ Johnson The lancet oncology 9 (6), 577-584, 2008 | 120 | 2008 |
| Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study SIR Noble, A Nelson, C Turner, IG Finlay Bmj 332 (7541), 577-580, 2006 | 119 | 2006 |
| Patients’ Experiences of LIving with CANcer-associated thrombosis: the PELICAN study S Noble, H Prout, A Nelson Patient preference and adherence, 337-345, 2015 | 108 | 2015 |
| Assessing patients’ anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology S Noble, A Matzdorff, A Maraveyas, MV Holm, G Pisa Haematologica 100 (11), 1486, 2015 | 102 | 2015 |
| Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study S Seaman, A Nelson, S Noble Patient preference and adherence, 453-461, 2014 | 101 | 2014 |
